NO316207B1 - Anvendelse av kaliumbikarbonat for fremstilling av en vandig, hellbar flytende sammensetning samt farmasöytisk preparat omfattende denne - Google Patents
Anvendelse av kaliumbikarbonat for fremstilling av en vandig, hellbar flytende sammensetning samt farmasöytisk preparat omfattende denne Download PDFInfo
- Publication number
- NO316207B1 NO316207B1 NO19973964A NO973964A NO316207B1 NO 316207 B1 NO316207 B1 NO 316207B1 NO 19973964 A NO19973964 A NO 19973964A NO 973964 A NO973964 A NO 973964A NO 316207 B1 NO316207 B1 NO 316207B1
- Authority
- NO
- Norway
- Prior art keywords
- volume
- weight
- natnum
- preparations
- aqueous
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title claims description 42
- 239000000203 mixture Substances 0.000 title claims description 14
- 239000007788 liquid Substances 0.000 title claims description 12
- 239000011736 potassium bicarbonate Substances 0.000 title claims description 9
- 229910000028 potassium bicarbonate Inorganic materials 0.000 title claims description 9
- 235000015497 potassium bicarbonate Nutrition 0.000 title claims description 9
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 title claims description 9
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 15
- 235000010443 alginic acid Nutrition 0.000 claims description 15
- 229920000615 alginic acid Polymers 0.000 claims description 15
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims description 13
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 13
- 229940072056 alginate Drugs 0.000 claims description 13
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 12
- 229920002125 Sokalan® Polymers 0.000 claims description 12
- 229960001631 carbomer Drugs 0.000 claims description 10
- 210000002784 stomach Anatomy 0.000 claims description 8
- 239000000375 suspending agent Substances 0.000 claims description 8
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 6
- 208000021302 gastroesophageal reflux disease Diseases 0.000 claims description 6
- 239000000825 pharmaceutical preparation Substances 0.000 claims description 6
- 201000006549 dyspepsia Diseases 0.000 claims description 5
- 208000008469 Peptic Ulcer Diseases 0.000 claims description 4
- 238000013268 sustained release Methods 0.000 claims description 3
- 239000012730 sustained-release form Substances 0.000 claims description 3
- 241000416162 Astragalus gummifer Species 0.000 claims description 2
- 229920001615 Tragacanth Polymers 0.000 claims description 2
- 235000010418 carrageenan Nutrition 0.000 claims description 2
- 229920001525 carrageenan Polymers 0.000 claims description 2
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims description 2
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims description 2
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims description 2
- 229960003943 hypromellose Drugs 0.000 claims description 2
- 239000001814 pectin Substances 0.000 claims description 2
- 229920001277 pectin Polymers 0.000 claims description 2
- 235000010987 pectin Nutrition 0.000 claims description 2
- 229960000292 pectin Drugs 0.000 claims description 2
- 239000008177 pharmaceutical agent Substances 0.000 claims description 2
- 229920001592 potato starch Polymers 0.000 claims description 2
- 229940071117 starch glycolate Drugs 0.000 claims description 2
- 235000010487 tragacanth Nutrition 0.000 claims description 2
- 239000000196 tragacanth Substances 0.000 claims description 2
- 229940116362 tragacanth Drugs 0.000 claims description 2
- 230000015572 biosynthetic process Effects 0.000 claims 1
- 230000008030 elimination Effects 0.000 claims 1
- 238000003379 elimination reaction Methods 0.000 claims 1
- 208000011906 peptic ulcer disease Diseases 0.000 claims 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 7
- 239000000047 product Substances 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 239000003755 preservative agent Substances 0.000 description 5
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- AEMOLEFTQBMNLQ-BZINKQHNSA-N D-Guluronic Acid Chemical compound OC1O[C@H](C(O)=O)[C@H](O)[C@@H](O)[C@H]1O AEMOLEFTQBMNLQ-BZINKQHNSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- AEMOLEFTQBMNLQ-UHFFFAOYSA-N beta-D-galactopyranuronic acid Natural products OC1OC(C(O)=O)C(O)C(O)C1O AEMOLEFTQBMNLQ-UHFFFAOYSA-N 0.000 description 3
- 239000008367 deionised water Substances 0.000 description 3
- 229910021641 deionized water Inorganic materials 0.000 description 3
- 210000003238 esophagus Anatomy 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 229910021645 metal ion Inorganic materials 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 2
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 239000000783 alginic acid Substances 0.000 description 2
- 229960001126 alginic acid Drugs 0.000 description 2
- 150000004781 alginic acids Chemical class 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- NKWPZUCBCARRDP-UHFFFAOYSA-L calcium bicarbonate Chemical compound [Ca+2].OC([O-])=O.OC([O-])=O NKWPZUCBCARRDP-UHFFFAOYSA-L 0.000 description 2
- 229910000020 calcium bicarbonate Inorganic materials 0.000 description 2
- 229910001424 calcium ion Inorganic materials 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- 210000003736 gastrointestinal content Anatomy 0.000 description 2
- -1 kahumbicarbonate Chemical class 0.000 description 2
- 239000012263 liquid product Substances 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 208000000689 peptic esophagitis Diseases 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 235000010413 sodium alginate Nutrition 0.000 description 2
- 239000000661 sodium alginate Substances 0.000 description 2
- 229940005550 sodium alginate Drugs 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- VQJMAIZOEPPELO-KYGIZGOZSA-N (1S,2S,6R,14R,15R,16R)-5-(cyclopropylmethyl)-16-(2-hydroxy-5-methylhexan-2-yl)-15-methoxy-13-oxa-5-azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]icosa-8(20),9,11-trien-11-ol hydrochloride Chemical compound Cl.CO[C@]12CC[C@@]3(C[C@@H]1C(C)(O)CCC(C)C)[C@H]1Cc4ccc(O)c5O[C@@H]2[C@]3(CCN1CC1CC1)c45 VQJMAIZOEPPELO-KYGIZGOZSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- WLAMNBDJUVNPJU-UHFFFAOYSA-N 2-methylbutyric acid Chemical compound CCC(C)C(O)=O WLAMNBDJUVNPJU-UHFFFAOYSA-N 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- IUPHTVOTTBREAV-UHFFFAOYSA-N 3-hydroxybutanoic acid;3-hydroxypentanoic acid Chemical compound CC(O)CC(O)=O.CCC(O)CC(O)=O IUPHTVOTTBREAV-UHFFFAOYSA-N 0.000 description 1
- 229920013642 Biopol™ Polymers 0.000 description 1
- 206010013911 Dysgeusia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- IAJILQKETJEXLJ-SQOUGZDYSA-N L-guluronic acid Chemical class O=C[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O IAJILQKETJEXLJ-SQOUGZDYSA-N 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- LCWAOCHOPBSGMU-UHFFFAOYSA-J aluminum;magnesium;sodium;hydrogen carbonate;oxygen(2-);silicon;trihydroxide Chemical compound [OH-].[OH-].[OH-].[O-2].[Na+].[Mg+2].[Al+3].[Si].OC([O-])=O LCWAOCHOPBSGMU-UHFFFAOYSA-J 0.000 description 1
- 229940069428 antacid Drugs 0.000 description 1
- 239000003159 antacid agent Substances 0.000 description 1
- 230000001458 anti-acid effect Effects 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000003613 bile acid Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 239000003405 delayed action preparation Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 229940045140 gaviscon Drugs 0.000 description 1
- 208000024798 heartburn Diseases 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 229910001415 sodium ion Inorganic materials 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/10—Carbonates; Bicarbonates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nutrition Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9504599.3A GB9504599D0 (en) | 1995-03-03 | 1995-03-03 | Improvements in or relating to organic compositions |
| PCT/GB1996/000358 WO1996027368A1 (en) | 1995-03-03 | 1996-02-16 | Liquid aqueous pharmaceutical compositions comprising sodium alginate and potassium bicarbonate |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO973964L NO973964L (no) | 1997-08-28 |
| NO973964D0 NO973964D0 (no) | 1997-08-28 |
| NO316207B1 true NO316207B1 (no) | 2003-12-29 |
Family
ID=10770811
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO19973964A NO316207B1 (no) | 1995-03-03 | 1997-08-28 | Anvendelse av kaliumbikarbonat for fremstilling av en vandig, hellbar flytende sammensetning samt farmasöytisk preparat omfattende denne |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US5681827A (cs) |
| EP (1) | EP0813407B1 (cs) |
| JP (1) | JPH11501044A (cs) |
| KR (1) | KR19980702689A (cs) |
| CN (1) | CN1123337C (cs) |
| AR (1) | AR004168A1 (cs) |
| AT (1) | ATE218853T1 (cs) |
| AU (1) | AU696480B2 (cs) |
| BR (2) | BR9607679A (cs) |
| CZ (1) | CZ289386B6 (cs) |
| DE (1) | DE69621785T2 (cs) |
| ES (1) | ES2174054T3 (cs) |
| GB (1) | GB9504599D0 (cs) |
| HK (1) | HK1007957A1 (cs) |
| HU (1) | HUP9801414A3 (cs) |
| NO (1) | NO316207B1 (cs) |
| NZ (1) | NZ301749A (cs) |
| PL (1) | PL184245B1 (cs) |
| PT (1) | PT813407E (cs) |
| TR (1) | TR199700891T1 (cs) |
| WO (1) | WO1996027368A1 (cs) |
| ZA (1) | ZA961517B (cs) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6099871A (en) * | 1995-06-01 | 2000-08-08 | Bristol-Myers Squibb Company | Anti-regurgitation infant formula |
| PL195031B1 (pl) * | 1997-04-30 | 2007-08-31 | Reckitt Benckiser Healthcare | Ciekła wodna kompozycja nadająca się do nalewaniazawierająca alginian i wodorowęglan metalu alkalicznego |
| US6027715A (en) * | 1998-03-02 | 2000-02-22 | Pozuelo; Jose | Composition and means for treating dry mouth |
| AU4759099A (en) * | 1998-09-21 | 2000-03-23 | Mcneil-Ppc, Inc. | Heat stable antacid and antigas suspensions |
| JP3959192B2 (ja) * | 1998-12-03 | 2007-08-15 | 株式会社大塚製薬工場 | 経管栄養食品 |
| US6351665B1 (en) | 1999-05-07 | 2002-02-26 | Kenneth L Koch | Method and apparatus for evaluating myoelectric signals and identifying artifact |
| GB2384986B (en) * | 2002-02-12 | 2004-01-07 | Reckitt Benckiser Healthcare | Compositions for the treatment of disorders of the upper gastrointestinal tract |
| SE530184C2 (sv) * | 2005-12-23 | 2008-03-18 | Kjell Stenberg | Bioadhesiv farmaceutisk filmkomposition innehållande lågviskösa alginater |
| EP2004138B1 (en) * | 2006-03-16 | 2013-11-20 | Glycologic Limited | Gastric raft composition comprising processed starches for inducing satiety |
| CN101641022A (zh) | 2007-02-13 | 2010-02-03 | S-生物技术控股有限责任公司 | 含有海藻酸盐的饮食产品 |
| US20080299182A1 (en) * | 2007-03-01 | 2008-12-04 | Shuyuan Zhang | Methods and formulations for topical gene therapy |
| KR100930809B1 (ko) * | 2008-02-13 | 2009-12-09 | (주)포테이토밸리 | 레드킹밸리 감자의 생즙 또는 전분을 유효성분으로함유하는 위염, 위궤양 및 십이지장궤양 예방 및 치료용약학조성물 |
| WO2010108494A1 (en) * | 2009-03-25 | 2010-09-30 | S-Biotek Holding Aps | Dayspepsia treatment with alginate |
| KR20120108218A (ko) * | 2011-03-23 | 2012-10-05 | 동아제약주식회사 | 위식도 역류질환 치료용 액상 타입 조성물 |
| WO2013055251A1 (ru) * | 2011-10-14 | 2013-04-18 | Общество С Ограниченной Ответственностью "Цитонир" | Пероральная фармацевтическая композиция для лечения воспалительных заболеваний желудочно-кишечного тракта |
| EP2806880B2 (en) * | 2012-01-27 | 2020-04-22 | Institute of Bioorganic Chemistry | Pharmaceutical composition as a substance for antireflux antacid drug |
| US9636360B2 (en) | 2012-09-18 | 2017-05-02 | pH Science Holdings, Inc | Method and composition for treating gastro-esophageal disorders |
| KR102303835B1 (ko) * | 2014-01-08 | 2021-09-16 | 영진약품 주식회사 | 수성의 유동성 액체 조성물 및 이의 제조방법 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1524740A (en) * | 1976-11-09 | 1978-09-13 | Reckitt & Colmann Prod Ltd | Pharmaceutical compositions for use in the suppression of gastric reflux |
| US4869902A (en) * | 1984-04-19 | 1989-09-26 | Rorer Pharmaceutical Corporation | Antacid composition |
| EP0179858B1 (en) * | 1984-04-19 | 1992-07-01 | Rhone-Poulenc Rorer International (Holdings) Inc. | Antacid composition |
| GB8618847D0 (en) * | 1986-08-01 | 1986-09-10 | Smith Kline French Lab | Pharmaceutical formulations |
| DK179687D0 (da) * | 1987-04-08 | 1987-04-08 | Farma Food As | Praeparat |
| AU627775B2 (en) * | 1988-09-20 | 1992-09-03 | Glaxo Group Limited | Pharmaceutical compositions |
-
1995
- 1995-03-03 GB GBGB9504599.3A patent/GB9504599D0/en active Pending
-
1996
- 1996-02-16 AT AT96903090T patent/ATE218853T1/de not_active IP Right Cessation
- 1996-02-16 CZ CZ19972749A patent/CZ289386B6/cs not_active IP Right Cessation
- 1996-02-16 DE DE69621785T patent/DE69621785T2/de not_active Expired - Lifetime
- 1996-02-16 EP EP96903090A patent/EP0813407B1/en not_active Expired - Lifetime
- 1996-02-16 PT PT96903090T patent/PT813407E/pt unknown
- 1996-02-16 ES ES96903090T patent/ES2174054T3/es not_active Expired - Lifetime
- 1996-02-16 PL PL96322044A patent/PL184245B1/pl not_active IP Right Cessation
- 1996-02-16 TR TR97/00891T patent/TR199700891T1/xx unknown
- 1996-02-16 KR KR1019970706096A patent/KR19980702689A/ko not_active Application Discontinuation
- 1996-02-16 BR BR9607679A patent/BR9607679A/pt not_active IP Right Cessation
- 1996-02-16 AU AU47244/96A patent/AU696480B2/en not_active Expired
- 1996-02-16 HU HU9801414A patent/HUP9801414A3/hu unknown
- 1996-02-16 WO PCT/GB1996/000358 patent/WO1996027368A1/en active IP Right Grant
- 1996-02-16 BR BRPI9607679-8B8D patent/BR9607679B8/pt unknown
- 1996-02-16 JP JP8526674A patent/JPH11501044A/ja not_active Ceased
- 1996-02-16 NZ NZ301749A patent/NZ301749A/en not_active IP Right Cessation
- 1996-02-16 CN CN96192336A patent/CN1123337C/zh not_active Expired - Lifetime
- 1996-02-23 US US08/606,198 patent/US5681827A/en not_active Expired - Lifetime
- 1996-02-26 ZA ZA961517A patent/ZA961517B/xx unknown
- 1996-02-27 AR ARP960101542A patent/AR004168A1/es active IP Right Grant
-
1997
- 1997-08-28 NO NO19973964A patent/NO316207B1/no unknown
-
1998
- 1998-06-27 HK HK98107193A patent/HK1007957A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0813407B1 (en) | 2002-06-12 |
| DE69621785T2 (de) | 2002-11-28 |
| AU696480B2 (en) | 1998-09-10 |
| AU4724496A (en) | 1996-09-23 |
| CN1177292A (zh) | 1998-03-25 |
| PL184245B1 (pl) | 2002-09-30 |
| NO973964L (no) | 1997-08-28 |
| PT813407E (pt) | 2002-10-31 |
| KR19980702689A (ko) | 1998-08-05 |
| TR199700891T1 (xx) | 1998-02-21 |
| NO973964D0 (no) | 1997-08-28 |
| AR004168A1 (es) | 1998-11-04 |
| CZ289386B6 (cs) | 2002-01-16 |
| BR9607679A (pt) | 1998-07-07 |
| HUP9801414A2 (hu) | 1999-01-28 |
| GB9504599D0 (en) | 1995-04-26 |
| BR9607679B8 (pt) | 2014-11-18 |
| CN1123337C (zh) | 2003-10-08 |
| HUP9801414A3 (en) | 2001-04-28 |
| US5681827A (en) | 1997-10-28 |
| PL322044A1 (en) | 1998-01-05 |
| HK1007957A1 (en) | 1999-04-30 |
| EP0813407A1 (en) | 1997-12-29 |
| NZ301749A (en) | 1998-05-27 |
| ATE218853T1 (de) | 2002-06-15 |
| WO1996027368A1 (en) | 1996-09-12 |
| ZA961517B (en) | 1996-09-03 |
| DE69621785D1 (de) | 2002-07-18 |
| CZ274997A3 (cs) | 1998-03-18 |
| ES2174054T3 (es) | 2002-11-01 |
| JPH11501044A (ja) | 1999-01-26 |
| MX9706661A (es) | 1997-11-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO316207B1 (no) | Anvendelse av kaliumbikarbonat for fremstilling av en vandig, hellbar flytende sammensetning samt farmasöytisk preparat omfattende denne | |
| CA2288743C (en) | Pourable alginate compositions | |
| EP0007619B1 (en) | Galactomannan polysaccharide gum formulation containing gellation inhibitor | |
| CN106456540B (zh) | 含铋的液体药物悬浮液 | |
| GB2298365A (en) | A Pharmaceutical Liquid Comprising Potassium Bicarbonate and Sodium Alginate | |
| GB2324725A (en) | Alinate/Alginic Acid Composition | |
| CA2592155C (en) | Process for producing jellylike drink | |
| CA2214343C (en) | Liquid aqueous pharmaceutical compositions comprising sodium alginate and potassium bicarbonate | |
| RU2173139C2 (ru) | Усовершенствования органических композиций или усовершенствования, относящиеся к этим композициям | |
| Nagarwal et al. | Phase transition system: novel oral in-situ gel | |
| MXPA97006661A (en) | Improvements in organic or related compositionswith | |
| GB2324724A (en) | A Concentrated Aqueous Sodium Alginate Composition | |
| US10206420B2 (en) | Methods for preparing alginate-based compositions | |
| AU2017265087B2 (en) | Pharmaceutical composition of sildenafil citrate in the form of a suspension for oral use | |
| JPH11137188A (ja) | 球状ゼリー食品 | |
| CA2614617A1 (en) | Pourable alginate compositions | |
| CZ380899A3 (cs) | Tekuté alginatové prostředky | |
| JPH012541A (ja) | ソ−ダゼリ−用セット |